Left atrial appendage occlusion: Opportunities and challenges

Journal of the American College of Cardiology

Volumn 63, Issue 4, 2014, Pages 291-298

  Holmes Jr , David R ^a   Lakkireddy, Dhanunjaya R ^b   Whitlock, Richard P ^c   Waksman, Ron ^d   Mack, Michael J ^e  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF KANSAS HOSPITAL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e Baylor Healthcare System   (United States)

Author keywords

left atrial appendage occlusion; nonvalvular atrial fibrillation; stroke prevention; Watchman device

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DABIGATRAN; RIVAROXABAN; WARFARIN; ANTIVITAMIN K;

ALTERNATIVE MEDICINE; AMPLATZER VASCULAR PLUG; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE REGISTRY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GUIDE WIRE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CATHETER; HEART DISEASE; HUMAN; IMPLANTABLE CLIP; INCIDENCE; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; LEFT ATRIAL APPENDAGE EXCLUSION; LEFT ATRIAL APPENDAGE OCCLUSION; PATIENT SELECTION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; ADVERSE OUTCOME; BRAIN ISCHEMIA; CHA2DS2 VASC SCORE; CHADS2 SCORE; CLINICAL STUDY; DEVICE THERAPY; DRUG EFFICACY; EMBOLISM; PREDICTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEPTAL OCCLUDER; THROMBOEMBOLISM;

AF; ATRIAL FIBRILLATION; CI; CONFIDENCE INTERVAL; INR; INTERNATIONAL NORMALIZED RATIO(S); LAA; LEFT ATRIAL APPENDAGE; LEFT ATRIAL APPENDAGE OCCLUSION; NOAC; NONVALVULAR ATRIAL FIBRILLATION; NOVEL ORAL ANTICOAGULANT; RATE RATIO; RR; STROKE PREVENTION; WATCHMAN DEVICE;

ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CLINICAL TRIALS AS TOPIC; HEMORRHAGE; HUMANS; PROSTHESES AND IMPLANTS; RISK ASSESSMENT; STROKE;

EID: 84893175659     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.1631     Document Type: Review

References (60)

1. O. Alli, and D.R. Holmes Jr. Left atrial appendage occlusion for stroke prevention Curr Probl Cardiol 37 2012 405 441
2. A.S. Go, E.M. Hylek, and K.A. Phillips et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375 (Pubitemid 32424106)
3. Y. Miyasaka, M.E. Barnes, and B.J. Gersh et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for further prevalence Circulation 114 2006 119 125 (Pubitemid 44420743)
4. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 1991 983 988
5. D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart study Circulation 110 2004 1042 1046 (Pubitemid 39319000)
6. J.L. Blackshear, and J.A. Odell Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation Ann Thorac Surg 61 1996 755 759 (Pubitemid 26060923)
7. D.R. Holmes Atrial fibrillation and stroke management: present and future Semin Neurol 30 2010 528 536
8. H.T. Tu, B.C. Campbell, S. Christensen for the EPITHET Investigators Pathophysiological determinants of worse stroke outcome in atrial fibrillation Cerebrovasc Dis 30 2010 389 395
9. T.K. Patel, C.W. Yancy, and B.P. Knight Left atrial appendage exclusion for stroke prevention in atrial fibrillation Cardiol Res Pract 2012 2012 610827
10. G.Y. Lip, L. Frison, J.L. Halperin, and D.A. Lane Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort Stroke 41 2010 2731 2738
11. J.B. Olesen, G.Y. Lip, and M.L. Hansen et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
12. T.P. Van Staa, E. Setakis, and G.L. Di Tanna et al. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice J Thromb Haemost 9 2010 39 48
13. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870 (Pubitemid 32537350)
14. 2 score of 1 who are unlikely to benefit from oral anticoagulant therapy Eur Heart J 34 2013 170 176
15. S. Apostolakis, D.A. Lane, Y. Guo, H. Buller, and G.Y. Lip Performance of the HEMMOR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients with Atrial Fibrillation) study J Am Coll Cardiol 60 2012 861 867
16. M.D. Ezekowitz, S.L. Bridgers, K.E. James for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
17. Stroke prevention in atrial fibrillation study: final results Circulation 84 1991 527 539
18. EAFT (European Atrial Fibrillation Trial) Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke Lancet 342 1993 1255 1262
19. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study Lancet 343 1994 687 691
20. P. Petersen, G. Boysen, J. Godtfredsen, E.D. Andersen, and B. Andersen Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study Lancet 1 1989 175 179 (Pubitemid 19038801)
21. R.G. Hart, O. Benavente, R. McBride, and L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501 (Pubitemid 29482392)
22. V. Fuster, L.E. Ryden, and D.S. Cannom et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 57 2011 e101 e298
23. A.J. Camm, G.Y. Lip, and R. De Caterina et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation Eur Heart J 33 2012 2719 2747
24. D.E. Singer, G.W. Albers, and J.E. Dalen et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 Suppl 6 2008 546S 592S (Pubitemid 351892972)
25. D.K. Wysowski, P. Nourjah, and L. Swartz Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action Arch Intern Med 167 2007 1414 1419 (Pubitemid 47052441)
26. C.S. Landefeld, and R.J. Beyth Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention Am J Med 95 1993 315 328 (Pubitemid 23270290)
27. M.C. Fang, A.S. Go, and Y. Chang et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages Am J Med 120 2007 700 705 (Pubitemid 47176507)
28. M. Sudlow, R. Thomson, B. Thwaites, H. Rodgers, and R.A. Kenny Prevalence of atrial fibrillation and eligibility for anticoagulants in the community Lancet 352 1998 1167 1171 (Pubitemid 28458530)
29. L.M. Brass, H.M. Krumholz, J.M. Scinto, and M. Radford Warfarin use among patients with atrial fibrillation Stroke 28 1997 2382 2389 (Pubitemid 28007636)
30. A.S. Go, E.M. Hylek, L.H. Borowsky, K.A. Phillips, J.V. Selby, and D.E. Singer Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the Anticoagulation and risk Factors in Atrial Fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934 (Pubitemid 30005032)
31. A.M. Gallagher, S. Rietbrock, J. Plumb, and T.P. van Staa Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 6 2008 1500 1506
32. H.D. White, M. Gruber, and J. Feyzi et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V Arch Intern Med 167 2007 239 245
33. M.L. Hansen, R. Sorensen, and M.T. Clausen et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 2010 1433 1441
34. P.P. Karjalainen, P. Porela, and A. Ylitalo et al. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting Eur Heart J 28 2007 726 732 (Pubitemid 46439228)
35. J.L. Orford, P. Fasseas, and S. Melby et al. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation Am Heart J 147 2004 463 467 (Pubitemid 38880866)
36. S.J. Connolly, M.D. Ezekowitz, S. Yusuf for the RE-LY Steering Committee and Investigators Dabigatran versus warfarin inpatients with atrial fibrillation N Engl J Med 361 2009 1139 1151
37. S.J. Connolly, L. Wallentin, and M.D. Ezekowitz et al. The Long-Term Multi-Center Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) study Circulation 128 2013 237 243
38. F.W. Verheugt New oral anticoagulants in atrial fibrillation forever? Circulation 128 2013 200 202
39. C.B. Granger, and L.V. Armaganijan Should newer oral anticoagulants be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism? Circulation 125 2012 159 164
40. W.L. Baker, and O.J. Phung Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation Circ Cardiovasc Qual Outcomes 5 2012 711 719
41. M.R. Patel, K.W. Mahaffey, J. Garg for the ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
42. C.B. Granger, J.H. Alexander, J.J. McMurray for the ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
43. S.J. Connolly, J. Eikelboom, C. Joyner for the AVERROES Steering Committee and Investigators Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
44. Majeed A, Hwang HG, Brueckmann M, et al. Management and outcomes of major bleeding on dabigatran or warfarin. Abstract presented at: American Society of Hematology Annual Meeting; December 8-11, 2012; Atlanta, GA.
45. H. Sievert, M.D. Lesh, and T. Trepels et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience Circulation 105 2002 1887 1889 (Pubitemid 34437613)
46. P.B. Sick, G. Schuler, and K.E. Hauptmann et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation J Am Coll Cardiol 49 2007 1490 1495 (Pubitemid 46505070)
47. D.R. Holmes, V.Y. Reddy, Z.G. Turi for the PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
48. V.Y. Reddy, D.R. Holmes, S.K. Doshi, P. Neuzil, and S. Kar Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry Circulation 123 2011 417 424
49. J.W. Park, A. Bethencourt, and H. Sievert et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience Catheter Cardiovasc Interv 77 2011 700 706
50. V.Y. Reddy, S.K. Doshi, H. Sievert for the PROTECT AF Investigators Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial Circulation 127 2013 720 729
51. S.M. Singh, S.R. Dukkipati, A. d'Avila, S.K. Doshi, and V.Y. Reddy Percutaneous left atrial appendage closure with an epicardial suture ligation approach: a prospective randomized pre-clinical feasibility study Heart Rhythm 7 2010 370 376
52. K. Bartus, F.T. Han, and J. Bednarek et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience J Am Coll Cardiol 62 2013 108 118
53. J.F. Viles-Gonzalez, S. Kar, and P. Douglas et al. The clinical impact of incomplete left atrial appendage closure with the Watchman device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation) substudy J Am Coll Cardiol 59 2012 923 929
54. V.Y. Reddy, S. Möbius-Winkler, and M.A. Miller et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology) J Am Coll Cardiol 61 2013 2551 2556
55. E.S. Katz, T. Tsiamtsiouris, R.M. Applebaum, A. Schwartzbard, P.A. Tunick, and I. Kronzon Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study J Am Coll Cardiol 36 2000 468 471 (Pubitemid 30624009)
56. A.S. Kanderian, A.M. Gillinov, G.B. Pettersson, E. Blackstone, and A.L. Klein Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography J Am Coll Cardiol 52 2008 924 929
57. S.P. Salzberg, A. Plass, and M.Y. Emmert et al. Left atrial appendage clip occlusion: early results J Thorac Cardiovasc Surg 139 2010 1269 1274
58. G. Ailawadi, M.W. Gerdisch, and R.L. Harvey et al. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial J Thorac Cardiovasc Surg 142 2011 1002 1009
59. D.A. Slater, A.J. Tatooles, and A. Coffey et al. Prospective clinical study of a novel left atrial appendage occlusion device Ann Thorac Surg 93 2012 2035 2040
60. J.D. Carroll, F.H. Edwards, and D. Marinac-Dabic et al. The STS-ACC Transcatheter Valve Therapy National Registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies J Am Coll Cardiol 62 2013 1026 1034